CBLB 612

• Description :

  CBLB 612 is an anti-radiation agent. CBLB 612 can be used in the propagation of mouse and monkey moderate stimulation hematopoietic stem cell (HSC), and lure that they are passed to peripheral blood from bone marrow into. CBLB 612 is an important auxiliary agent for cancer[1].

• UNSPSC :

  12352209

• Target :

  Others

• Type :

  Peptides

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/cblb-612.html

• Solubility :

  10 mM in DMSO

• Smiles :

  CCCCCCCCCCCCCCCC(OC[C@H](OC(CCCCCCCCCCCCCCC)=O)CSC[C@H](N)C(N[C@@H](C(C)C)C(N[C@@H](CCC(N)=O)C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@H](C(O)=O)CCCCN)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O

• Molecular Formula :

  C77H135N13O24S

• Molecular Weight :

  1659.03

• References & Citations :

  [1]Cao J, et al. Pharmaceutical composition containing CBLB612 and used in anti-radiation auxiliary drug or anti-tumor auxiliary drug. China, CN104027791 A. 2014-09-10.|[2]Cao Jinquan. Pharmaceutical composition. Patent. CN104027791.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Peptides

• Clinical Information :

  Phase 2

• CAS Number :

  [1039381-80-0]